2,3,4,5-tetrahydroxypentanal has been researched along with Atherogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, Y | 1 |
| Zhang, M | 1 |
| Zhao, P | 1 |
| Jia, M | 1 |
| Liu, B | 1 |
| Jia, Q | 1 |
| Guo, J | 1 |
| Dou, L | 1 |
| Li, J | 1 |
1 other study available for 2,3,4,5-tetrahydroxypentanal and Atherogenesis
| Article | Year |
|---|---|
Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Diet; Disease Models, Animal; Endothel | 2017 |